Buy Reata Pharmaceuticals Stock | RETA Stock Price & Latest News | Public
RETA

Reata Pharmaceuticals

$0.00 (0.00%)Today

    About RETA

    Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -1.97
    -3.94
    -5.91
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$1.99

    Actual EPS
    Q3 2020

    Stats

    Market Cap$3,15B
    Volume43,9k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$257.96
    1 Year Low$73.38
    Open$101.68
    High$101.68
    Low$92.00

    Buy any stock with any amount of money.

    Download the App
    Download the app